AR and posterior cortical atrophy: AR induces a metabolic reprogramming encompassing hZIP1 zinc transporter downregulation that leads to low mitochondrial zinc levels [57, 58] and m‐aconitase reactivation, restoring the TCA cycle [59], and increasing the susceptibility of PCa cells to OXPHOS inhibitors [60].